Blue Owl Capital Holdings LP 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:09 pm Purchase |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Blue Owl Capital Holdings LP | 6,357,928 8.480% |
946,638 (+17.49%) |
Filing |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Blue Owl Capital Holdings LP | 4,091,118 8.480% |
4,091,118 (New Position) |
Filing |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Blue Owl Capital Holdings LP | 5,411,290 7.220% |
5,411,290 (New Position) |
Filing |